A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

NCT00823992 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: placebo
DRUG: taspoglutide

Sponsor

Hoffmann-La Roche